Leerink Healthcare Services and Technology Team
Trending Content - Investment Banking Forum
Career Resources
WSO Free Modeling Series - Now Open Through
August 31, 2026
9 Free Financial Modeling Lessons
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
+Bonus: Get 27 financial modeling templates in swipe file
+Bonus: Get 27 financial modeling templates in swipe file
High Finance Applications
Guaranteed
Get at least one offer GUARANTEED
- 1:1 support
- 92% success rate
- 2,000+ mentor network
- Unlimited Live bootcamps
- AI for resume + LinkedIn
- Networking automation tools
- HireVue simulation tool
- Full course library
- Private Slack community
- 20hrs of mocks
- + much more...
SVB Leerink has been actively involved in significant transactions, particularly in the healthcare sector. They advised on the $3.3 billion sale of Dicerna to Novo Nordisk, showcasing their capability in handling large-scale deals in the healthcare industry. Additionally, their recent expansion into technology, with the advising on the $5.4 billion sale of Quest Software to Clearlake Capital, indicates a growing competence in tech-related financial services as well.
Regarding the healthcare services practices specifically at Leerink, while the context does not provide details about closed deals on their website or the return rate for past summers, the lateral moves of analysts to prestigious firms like Moelis M&A, MS M&A, and Jefferies HC suggest that Leerink is considered a solid group to join. These transitions imply that the experience and exposure gained at Leerink are valuable and recognized within the industry, making it a potentially good career move.
Sources: Is SVB Leerink Becoming an EB?, Is Leerink Turning Into EB?, Jefferies SA 2023, Credit Suisse, Barclays, and Jefferies Healthcare, Is Leerink Turning Into EB?
bump - curious as well
I mean all the banks that you listed out are significant level ups so makes sense.
Not sure what time period those laterals occurred, but it had deal flow up until last year when there was an exodus of senior bankers. I cannot imagine you will get good reps at anything outside of Biopharma at Leerink any longer.
Those laterals occured in recent 6 months
How long were they at SVB? They probably got a few deals done if they had been there for at least a year or longer.
Yes that makes sense - some of them joined at summer 2022 so probly had some experiences, but two guys who joined at summer 23 and lateraled to Moelis M&A and HL hc within a year and I don't know how they did it
Est ducimus nostrum porro est impedit dolor. Totam quod nihil nostrum nihil nihil. Aliquam vel voluptas et reiciendis laborum eveniet. Autem sit maiores voluptatibus.
Molestiae autem deserunt qui eos non ad. Magni doloribus et adipisci assumenda quia quo fugit qui. Quia perspiciatis temporibus quia.
Quaerat dolorem iure at exercitationem voluptates autem. Et labore nulla neque eos facilis nam dignissimos et. Animi et nam voluptatem. Dolor temporibus veniam quisquam hic cumque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...